' 
![]()
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.3
USERS' SCORE
Excellent
Based on 52 Reviews
9.1
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
N-acetyl-L-cysteine
600 mg
**
Top Medical Research Studies
8
NAC enhances bronchitis management in COPD
The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine.
Relevance score reflects study focus
We explored how N-acetylcysteine (NAC), a common mucolytic agent, plays a role in treating bronchitis associated with chronic obstructive pulmonary disease (COPD). This study focused on the treatable traits (TT) strategy, which aims to identify and manage specific traits of COPD that are clinically significant and manageable.
Our findings indicate that NAC is particularly valuable for patients experiencing a frequent productive cough, a common trait of bronchitis in COPD. Not only does it help reduce mucus buildup, but it also appears to have benefits for reducing airway inflammation and limitations in airflow.
Interestingly, the research highlights that NAC’s antioxidant and anti-inflammatory properties can support various symptoms linked to bronchitis. By adopting the TT strategy, including NAC in the treatment plan, we observed improvements in lung function and overall quality of life for patients, while minimizing unnecessary medication.
Thus, incorporating NAC into bronchitis management within the framework of personalized medicine shows promising potential to help patients manage their symptoms better and enhance their daily lives.
Our findings indicate that NAC is particularly valuable for patients experiencing a frequent productive cough, a common trait of bronchitis in COPD. Not only does it help reduce mucus buildup, but it also appears to have benefits for reducing airway inflammation and limitations in airflow.
Interestingly, the research highlights that NAC’s antioxidant and anti-inflammatory properties can support various symptoms linked to bronchitis. By adopting the TT strategy, including NAC in the treatment plan, we observed improvements in lung function and overall quality of life for patients, while minimizing unnecessary medication.
Thus, incorporating NAC into bronchitis management within the framework of personalized medicine shows promising potential to help patients manage their symptoms better and enhance their daily lives.
Read More
7
NAC enhances phage therapy efficacy
Synergistic action of mucoactive drugs and phages against and .
Study assesses NAC's role
Our investigation delves into how N-acetylcysteine (NAC) impacts the treatment of bronchitis when used alongside phage therapy. We specifically looked at the interactions between NAC and certain bacterial strains known to cause lower respiratory tract infections.
Through our study, we discovered that NAC could act as an adjuvant, enhancing the effectiveness of phages in fighting these bacterial pathogens. Under certain conditions, NAC appeared to make bacteria more susceptible to phage infection, which could facilitate better treatment outcomes.
However, we also noted that the effectiveness of this combination depends on various factors, including the specific characteristics of the phages and the surrounding environment. Different outcomes were observed in terms of how phages interacted with bacteria, emphasizing the need for further research to fully understand this complex relationship.
Overall, this study provides insights into optimizing treatment strategies for bronchitis, especially in an era of rising antibiotic resistance, by combining mucoactive agents like NAC with innovative therapies such as phage therapy.
Through our study, we discovered that NAC could act as an adjuvant, enhancing the effectiveness of phages in fighting these bacterial pathogens. Under certain conditions, NAC appeared to make bacteria more susceptible to phage infection, which could facilitate better treatment outcomes.
However, we also noted that the effectiveness of this combination depends on various factors, including the specific characteristics of the phages and the surrounding environment. Different outcomes were observed in terms of how phages interacted with bacteria, emphasizing the need for further research to fully understand this complex relationship.
Overall, this study provides insights into optimizing treatment strategies for bronchitis, especially in an era of rising antibiotic resistance, by combining mucoactive agents like NAC with innovative therapies such as phage therapy.
Read More
7
Mucolytics show limited efficacy
Efficacy and safety of mucolytics in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Evaluated general effectiveness
We examined the effectiveness of n-acetyl-l-cysteine, a mucolytic agent, in treating patients with stable chronic obstructive pulmonary disease (COPD). In our analysis, we looked at randomized controlled trials which highlighted various mucolytics including n-acetyl-l-cysteine, ambroxol, and others.
While mucolytics like n-acetyl-l-cysteine showed promise in reducing exacerbations and hospitalizations among patients, it did not significantly improve other outcomes related to bronchitis or lung function, such as mortality or work absenteeism. The results suggested a reduction in the rate of exacerbations and a tendency towards better outcomes in those who experienced two or more exacerbations, yet no improvement was seen in overall lung function tests.
Importantly, the safety profile of mucolytics was comparable to that of a placebo, indicating that patients can tolerate this treatment without serious side effects. Overall, while we recognized some benefits, it is clear that n-acetyl-l-cysteine might not be a game changer for bronchitis management.
While mucolytics like n-acetyl-l-cysteine showed promise in reducing exacerbations and hospitalizations among patients, it did not significantly improve other outcomes related to bronchitis or lung function, such as mortality or work absenteeism. The results suggested a reduction in the rate of exacerbations and a tendency towards better outcomes in those who experienced two or more exacerbations, yet no improvement was seen in overall lung function tests.
Importantly, the safety profile of mucolytics was comparable to that of a placebo, indicating that patients can tolerate this treatment without serious side effects. Overall, while we recognized some benefits, it is clear that n-acetyl-l-cysteine might not be a game changer for bronchitis management.
Read More
Most Useful Reviews
9.5
Effective bronchitis treatment
I was initially sceptical about the quality of Life Extension N-Acetyl-L-Cysteine (NAC) due to its lower price. However, I have found it very effective for treating bronchitis. Whenever I begin to cough or develop a cold, I start taking NAC, and it often prevents the bronchitis from worsening. It worked well for my latest cold, and I intend to keep using this brand because it’s effective and reasonably priced.
Read More
10
Breath easier now
Absolutely love it! If you suffer from asthma, COPD, chronic bronchitis, or feel a cold settling in your chest, take this! I’ve struggled with chronic allergies that escalate into chest issues. I started taking two daily for a couple of weeks to support my breathing. I hadn't been able to inflate a balloon for years without feeling dizzy! This past summer, I inflated multiple pool floats simultaneously; the only product I was using was N-Acetyl Cysteine. Each time I tested this product, I achieved positive results! I wholeheartedly recommend it for anyone facing breathing challenges. It's safe, affordable, and effective!
Read More
9.5
Excellent for bronchitis
This treatment is like an emergency remedy for coughs and bronchitis. It significantly helps in clearing phlegm from the lungs, working better than other substitutes like ACC. It's particularly useful post-bronchitis and after illnesses such as COVID-19. Plus, it effectively detoxifies the body after a night of drinking. Highly recommend!
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.3
8
NAC enhances bronchitis management in COPD
The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine.
Relevance score reflects study focus
We explored how N-acetylcysteine (NAC), a common mucolytic agent, plays a role in treating bronchitis associated with chronic obstructive pulmonary disease (COPD). This study focused on the treatable traits (TT) strategy, which aims to identify and manage specific traits of COPD that are clinically significant and manageable.
Our findings indicate that NAC is particularly valuable for patients experiencing a frequent productive cough, a common trait of bronchitis in COPD. Not only does it help reduce mucus buildup, but it also appears to have benefits for reducing airway inflammation and limitations in airflow.
Interestingly, the research highlights that NAC’s antioxidant and anti-inflammatory properties can support various symptoms linked to bronchitis. By adopting the TT strategy, including NAC in the treatment plan, we observed improvements in lung function and overall quality of life for patients, while minimizing unnecessary medication.
Thus, incorporating NAC into bronchitis management within the framework of personalized medicine shows promising potential to help patients manage their symptoms better and enhance their daily lives.
Our findings indicate that NAC is particularly valuable for patients experiencing a frequent productive cough, a common trait of bronchitis in COPD. Not only does it help reduce mucus buildup, but it also appears to have benefits for reducing airway inflammation and limitations in airflow.
Interestingly, the research highlights that NAC’s antioxidant and anti-inflammatory properties can support various symptoms linked to bronchitis. By adopting the TT strategy, including NAC in the treatment plan, we observed improvements in lung function and overall quality of life for patients, while minimizing unnecessary medication.
Thus, incorporating NAC into bronchitis management within the framework of personalized medicine shows promising potential to help patients manage their symptoms better and enhance their daily lives.
Read More
7
NAC enhances phage therapy efficacy
Synergistic action of mucoactive drugs and phages against and .
Study assesses NAC's role
Our investigation delves into how N-acetylcysteine (NAC) impacts the treatment of bronchitis when used alongside phage therapy. We specifically looked at the interactions between NAC and certain bacterial strains known to cause lower respiratory tract infections.
Through our study, we discovered that NAC could act as an adjuvant, enhancing the effectiveness of phages in fighting these bacterial pathogens. Under certain conditions, NAC appeared to make bacteria more susceptible to phage infection, which could facilitate better treatment outcomes.
However, we also noted that the effectiveness of this combination depends on various factors, including the specific characteristics of the phages and the surrounding environment. Different outcomes were observed in terms of how phages interacted with bacteria, emphasizing the need for further research to fully understand this complex relationship.
Overall, this study provides insights into optimizing treatment strategies for bronchitis, especially in an era of rising antibiotic resistance, by combining mucoactive agents like NAC with innovative therapies such as phage therapy.
Through our study, we discovered that NAC could act as an adjuvant, enhancing the effectiveness of phages in fighting these bacterial pathogens. Under certain conditions, NAC appeared to make bacteria more susceptible to phage infection, which could facilitate better treatment outcomes.
However, we also noted that the effectiveness of this combination depends on various factors, including the specific characteristics of the phages and the surrounding environment. Different outcomes were observed in terms of how phages interacted with bacteria, emphasizing the need for further research to fully understand this complex relationship.
Overall, this study provides insights into optimizing treatment strategies for bronchitis, especially in an era of rising antibiotic resistance, by combining mucoactive agents like NAC with innovative therapies such as phage therapy.
Read More
7
Mucolytics show limited efficacy
Efficacy and safety of mucolytics in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Evaluated general effectiveness
We examined the effectiveness of n-acetyl-l-cysteine, a mucolytic agent, in treating patients with stable chronic obstructive pulmonary disease (COPD). In our analysis, we looked at randomized controlled trials which highlighted various mucolytics including n-acetyl-l-cysteine, ambroxol, and others.
While mucolytics like n-acetyl-l-cysteine showed promise in reducing exacerbations and hospitalizations among patients, it did not significantly improve other outcomes related to bronchitis or lung function, such as mortality or work absenteeism. The results suggested a reduction in the rate of exacerbations and a tendency towards better outcomes in those who experienced two or more exacerbations, yet no improvement was seen in overall lung function tests.
Importantly, the safety profile of mucolytics was comparable to that of a placebo, indicating that patients can tolerate this treatment without serious side effects. Overall, while we recognized some benefits, it is clear that n-acetyl-l-cysteine might not be a game changer for bronchitis management.
While mucolytics like n-acetyl-l-cysteine showed promise in reducing exacerbations and hospitalizations among patients, it did not significantly improve other outcomes related to bronchitis or lung function, such as mortality or work absenteeism. The results suggested a reduction in the rate of exacerbations and a tendency towards better outcomes in those who experienced two or more exacerbations, yet no improvement was seen in overall lung function tests.
Importantly, the safety profile of mucolytics was comparable to that of a placebo, indicating that patients can tolerate this treatment without serious side effects. Overall, while we recognized some benefits, it is clear that n-acetyl-l-cysteine might not be a game changer for bronchitis management.
Read More
User Reviews
USERS' SCORE
Excellent
Based on 52 Reviews
9.1
10
Prevents chest infections
Before taking this daily, I used to frequently get chest infections after just a cold. Now, if I do get one, it’s much milder. I believe N-acetyl cysteine works similarly for me as it does for cystic fibrosis patients. If you have similar issues, I recommend trying it.
10
Seasonal bronchitis relief
It's a lifesaver against my seasonal bronchitis. I used to suffer greatly until I discovered NAC, which has diminished my excessive coughing. I’m very content with it, and it’s always in my medical kit.
10
Breath easier now
Absolutely love it! If you suffer from asthma, COPD, chronic bronchitis, or feel a cold settling in your chest, take this! I’ve struggled with chronic allergies that escalate into chest issues. I started taking two daily for a couple of weeks to support my breathing. I hadn't been able to inflate a balloon for years without feeling dizzy! This past summer, I inflated multiple pool floats simultaneously; the only product I was using was N-Acetyl Cysteine. Each time I tested this product, I achieved positive results! I wholeheartedly recommend it for anyone facing breathing challenges. It's safe, affordable, and effective!
Read More
9.5
Effective bronchitis treatment
I was initially sceptical about the quality of Life Extension N-Acetyl-L-Cysteine (NAC) due to its lower price. However, I have found it very effective for treating bronchitis. Whenever I begin to cough or develop a cold, I start taking NAC, and it often prevents the bronchitis from worsening. It worked well for my latest cold, and I intend to keep using this brand because it’s effective and reasonably priced.
Read More
9.5
Excellent for bronchitis
This treatment is like an emergency remedy for coughs and bronchitis. It significantly helps in clearing phlegm from the lungs, working better than other substitutes like ACC. It's particularly useful post-bronchitis and after illnesses such as COVID-19. Plus, it effectively detoxifies the body after a night of drinking. Highly recommend!
Read More
